共 50 条
Bone Mineral Density and Trabecular Bone Score Changes throughout Menopause in Women with HIV
被引:1
|作者:
Milic, Jovana
[1
,2
]
Renzetti, Stefano
[3
]
Morini, Denise
[4
]
Motta, Federico
[2
]
Carli, Federica
[5
]
Menozzi, Marianna
[5
]
Cuomo, Gianluca
[5
]
Mancini, Giuseppe
[5
]
Simion, Mattia
[5
]
Romani, Federico
[5
]
Spadoni, Anna
[5
]
Baldisserotto, Irene
[5
]
Barp, Nicole
[5
]
Diazzi, Chiara
[6
]
Mussi, Chiara
[7
]
Mussini, Cristina
[2
,5
]
Rochira, Vincenzo
[6
,8
]
Calza, Stefano
[9
]
Guaraldi, Giovanni
[1
,2
,5
]
机构:
[1] Univ Modena & Reggio Emilia, Modena HIV Metab Clin, I-41121 Modena, Italy
[2] Univ Modena & Reggio Emilia, Dept Surg Med Dent & Morphol Sci, I-41121 Modena, Italy
[3] Univ Brescia, Dept Med Surg Specialties Radiol Sci & Publ Hlth, I-25121 Brescia, Italy
[4] Univ Hosp San Giovanni di Dio & Ruggi dAragona, Hematol & Transplant Ctr, I-84121 Salerno, Italy
[5] Azienda Osped Univ, Dept Infect Dis, Policlin Modena, I-41121 Modena, Italy
[6] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Unit Endocrinol, I-41126 Modena, Italy
[7] Univ Modena & Reggio Emilia, Dept Biomed & Metab Sci & Neurosci, I-41126 Modena, Italy
[8] Azienda Osped Univ Modena, Osped Civile Baggiovara, Dept Med Specialties, Unit Endocrinol, I-41126 Modena, Italy
[9] Univ Brescia, Dept Mol & Translat Med, I-25121 Brescia, Italy
来源:
关键词:
bone mineral density;
trabecular bone score;
menopause;
women with HIV;
TENOFOVIR DISOPROXIL FUMARATE;
ANTIRETROVIRAL THERAPY;
ABACAVIR-LAMIVUDINE;
INFECTION;
MICROARCHITECTURE;
RECOMMENDATIONS;
MANAGEMENT;
DISEASE;
RISK;
EMTRICITABINE;
D O I:
10.3390/v15122375
中图分类号:
Q93 [微生物学];
学科分类号:
071005 ;
100705 ;
摘要:
Objective: The objectives of this study were to describe the trajectories of bone mineral density (BMD) and trabecular bone score (TBS) changes throughout pre-menopause (reproductive phase and menopausal transition) and post-menopause (early and late menopause) in women with HIV (WWH) undergoing different antiretroviral therapies (ARTs) and explore the risk factors associated with those changes. Methods: This was an observational longitudinal retrospective study in WWH with a minimum of two DEXA evaluations comprising BMD and TBS measurements, both in the pre-menopausal and post-menopausal periods. Menopause was determined according to the STRAW+10 criteria, comprising four periods: the reproductive period, menopausal transition, and early- and late-menopausal periods. Mixed-effects models were fitted to estimate the trajectories of the two outcomes (BMD and TBS) over time. Annualized lumbar BMD and TBS absolute and percentage changes were calculated in each STRAW+10 time window. A backward elimination procedure was applied to obtain the final model, including the predictors that affected the trajectories of BMD or TBS over time. Results: A total of 202 WWH, all Caucasian, were included. In detail, 1954 BMD and 195 TBS data were analyzed. The median number of DEXA evaluations per woman was 10 (IQR: 7, 12). The median observation periods per patient were 12.0 years (IQR = 8.9-14.4) for BMD and 6.0 years (IQR: 4.3, 7.9) for TBS. The prevalence of osteopenia (63% vs. 76%; p < 0.001) and osteoporosis (16% vs. 36%; p < 0.001) increased significantly between the pre-menopausal and post-menopausal periods. Both BMD (1.03 (+/- 0.14) vs. 0.92 (+/- 0.12) g/cm2; p < 0.001) and TBS (1.41 (IQR: 1.35, 1.45) vs. 1.32 (IQR: 1.28, 1.39); p < 0.001) decreased significantly between the two periods. The trend in BMD decreased across the four STRAW+10 periods, with a slight attenuation only in the late-menopausal period when compared with the other intervals. The TBS slope did not significantly change throughout menopause. The delta mean values of TBS in WWH were lower between the menopausal transition and reproductive period compared with the difference between menopause and menopausal transition. Conclusions: Both BMD and TBS significantly decreased over time. The slope of the change in BMD and TBS significantly decreased in the menopausal transition, suggesting that this period should be considered by clinicians as a key time during which to assess bone health and modifiable risk factors in WWH.
引用
收藏
页数:15
相关论文